TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
Xinyi LiLele LiuXingguo SongKangyu WangLimin NiuLi XieXian-Rang SongPublished in: Journal of cancer research and clinical oncology (2021)
Our data suggested that lncRNAs sequestered in TEPs enabled blood-based lung cancer diagnosis and progression prediction.